TENS Therapy Failed to Reduce IUD Insertion Pain

A recent study found no significant pain relief from electrical nerve stimulation during intrauterine device placement.

Updated on Oct. 13, 2026 in Women’s Health

A sterile, brightly lit medical examination room containing a stainless steel tray with clean, non-descript clinical instruments.
A recent clinical trial published October 8, 2026, found that TENS therapy provides no significant pain relief for patients undergoing IUD insertion. AI Illustration. Upload story photo >

Live Poll

Do you generally trust that add-on pain relief interventions for minor procedures are effective?

A randomized controlled trial published October 8, 2026, determined that transcutaneous electrical nerve stimulation (TENS) provided no pain reduction during IUD insertion compared to a sham treatment. The study, which evaluated 98 adult participants, indicates the intervention did not improve the patient experience for those undergoing the procedure.

Why it matters

Managing discomfort during IUD insertion is a common clinical priority, but this research suggests that high-frequency TENS may not be an effective tool for pain control. Patients should discuss alternative pain management options with their physician, as individual experiences vary significantly based on medical history.

In a randomized controlled trial of 98 adults with a median age of 29, researchers compared 80 Hz TENS against a sham device during IUD insertion. Results showed no significant difference in pain scores between the two groups.

The players

Mount Sinai Medical System

A comprehensive academic health system that serves as a clinical site for research on gynecological procedures.

Yale New Haven Health System

A major academic health network that facilitates research in women's health and reproductive care.

The details

The trial involved participants receiving either active high-frequency TENS at 80 Hz or a sham device, alongside standardized oral ibuprofen (600-800 mg) and transabdominal ultrasound guidance. While the TENS group reported a higher likelihood of recommending the intervention to a friend, this subjective assessment did not correlate with measurable pain reductions. Clinicians in the study consistently underestimated patient-reported pain scores, which averaged 60.5 mm compared to the 48.9 mm they estimated.

Timeline

  1. March 2024 to April 2025: IUD insertions performed at Mount Sinai Medical System.

  2. January 2025 to April 2025: IUD insertions performed at Yale New Haven Health.

  3. October 8, 2026: Study published in American Journal of Obstetrics and Gynecology.

Health Landscape

This study adds to the growing body of literature evaluating pain management protocols for common gynecological procedures. It highlights the importance of clinical trial validation when adopting new supportive care measures in reproductive health.

If you are planning an IUD insertion, discuss effective pain management strategies and expectations with your healthcare provider. Be aware that nulliparous patients in this study reported higher pain levels, and communicating your personal comfort needs remains a vital part of the procedure.

The takeaway

While TENS therapy did not reduce pain in this study, the findings underscore the importance of realistic expectations for in-office procedures. Talk to your physician about the full range of available pain relief options to ensure your comfort during an upcoming appointment.

Further reading

For more on evolving standards for reproductive care, visit the Women’s Health section.

Source note: This article includes information reported by Medscape.

Live Poll

Do you generally trust that add-on pain relief interventions for minor procedures are effective?